Mostrar el registro sencillo del ítem

dc.contributor.authorBird, Thomas G
dc.contributor.authorMüller, Miryam
dc.contributor.authorBoulter, Luke
dc.contributor.authorVincent, David F
dc.contributor.authorRidgway, Rachel A
dc.contributor.authorLopez-Guadamillas, Elena
dc.contributor.authorLu, Wei-Yu
dc.contributor.authorJamieson, Thomas
dc.contributor.authorGovaere, Olivier
dc.contributor.authorCampbell, Andrew D
dc.contributor.authorFerreira-Gonzalez, Sofía
dc.contributor.authorCole, Alicia M
dc.contributor.authorHay, Trevor
dc.contributor.authorSimpson, Kenneth J
dc.contributor.authorClark, William
dc.contributor.authorHedley, Ann
dc.contributor.authorClarke, Mairi
dc.contributor.authorGentaz, Pauline
dc.contributor.authorNixon, Colin
dc.contributor.authorBryce, Steven
dc.contributor.authorKiourtis, Christos
dc.contributor.authorSprangers, Joep
dc.contributor.authorNibbs, Robert J B
dc.contributor.authorVan Rooijen, Nico
dc.contributor.authorBartholin, Laurent
dc.contributor.authorMcGreal, Steven R
dc.contributor.authorApte, Udayan
dc.contributor.authorBarry, Simon T
dc.contributor.authorIredale, John P
dc.contributor.authorClarke, Alan R
dc.contributor.authorSerrano, Manuel
dc.contributor.authorRoskams, Tania A
dc.contributor.authorSansom, Owen J
dc.contributor.authorForbes, Stuart J
dc.date.accessioned2024-02-28T11:16:19Z
dc.date.available2024-02-28T11:16:19Z
dc.date.issued2018-08-15
dc.identifier.citationSci Transl Med. 2018;10(454):eaan1230.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18862
dc.description.abstractLiver injury results in rapid regeneration through hepatocyte proliferation and hypertrophy. However, after acute severe injury, such as acetaminophen poisoning, effective regeneration may fail. We investigated how senescence may underlie this regenerative failure. In human acute liver disease, and murine models, p21-dependent hepatocellular senescence was proportionate to disease severity and was associated with impaired regeneration. In an acetaminophen injury mouse model, a transcriptional signature associated with the induction of paracrine senescence was observed within 24 hours and was followed by one of impaired proliferation. In mouse genetic models of hepatocyte injury and senescence, we observed transmission of senescence to local uninjured hepatocytes. Spread of senescence depended on macrophage-derived transforming growth factor-β1 (TGFβ1) ligand. In acetaminophen poisoning, inhibition of TGFβ receptor 1 (TGFβR1) improved mouse survival. TGFβR1 inhibition reduced senescence and enhanced liver regeneration even when delivered beyond the therapeutic window for treating acetaminophen poisoning. This mechanism, in which injury-induced senescence impairs liver regeneration, is an attractive therapeutic target for developing treatments for acute liver failure.es_ES
dc.description.sponsorshipT. G. B. was funded by the Wellcome Trust (WT081604AIA and WT107492Z). S. J. F. was funded by a Medical Research Council (MRC) project grant (G1000868), the Wellcome Trust, the Sir Jules Thorn Charitable Trust, and Scottish Enterprise. J. P. I. was supported by an MRC program grant. O. J. S. was supported by CRUK grant #A12481. U.A. was supported by NIH grant #R01 DK98414.es_ES
dc.language.isoenges_ES
dc.publisherAmerican Association for the Advancement of Science (AAAS) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshCellular Senescence es_ES
dc.subject.meshLiver Regeneration es_ES
dc.subject.meshParacrine Communication es_ES
dc.subject.meshAnimals es_ES
dc.subject.meshCyclin-Dependent Kinase Inhibitor p21 es_ES
dc.subject.meshDisease Models, Animales_ES
dc.subject.meshHepatocytes es_ES
dc.subject.meshHumans es_ES
dc.subject.meshLiver es_ES
dc.subject.meshMacrophages es_ES
dc.subject.meshMale es_ES
dc.subject.meshMice, Inbred C57BL es_ES
dc.subject.meshNecrosis es_ES
dc.subject.meshSignal Transduction es_ES
dc.subject.meshTransforming Growth Factor beta es_ES
dc.titleTGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID30111642es_ES
dc.format.volume10es_ES
dc.format.number454es_ES
dc.identifier.doi10.1126/scitranslmed.aan1230es_ES
dc.contributor.funderWellcome Trust es_ES
dc.contributor.funderUK Research and Innovation es_ES
dc.contributor.funderMedical Research Council UK (MRC)es_ES
dc.contributor.funderUnited States Department of Health and Human Services es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1946-6242es_ES
dc.relation.publisherversionhttps://doi.org/10.1126/scitranslmed.aan1230es_ES
dc.identifier.journalScience translational medicinees_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Supresión Tumorales_ES
dc.identifier.pmchttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420144/
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 Internacional